Effects of serotonin 5-HT3 receptor antagonists on CRF-induced abnormal colonic water transport and defecation in rats

被引:13
作者
Hirata, Takuya [1 ]
Keto, Yoshihiro [1 ]
Nakata, Mari [1 ]
Takeuchi, Asako [1 ]
Funatsu, Toshiyuki [1 ]
Akuzawa, Shinobu [1 ]
Sasamata, Masao [1 ]
Miyata, Keiji [1 ]
机构
[1] Astellas Pharma Inc, Drug Discovery Res, Appl Pharmacol Res Labs, Tsukuba, Ibaraki 3058585, Japan
关键词
abnormal defecation; colonic water transport; CRF; 5-HT3 receptor antagonist; (rat);
D O I
10.1016/j.ejphar.2008.03.040
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of corticotropin releasing factor (CRF) and serotonin (5-HT)(3) receptor antagonists on intestinal water transport are not well understood. Hence, we established a CRF-induced abnormal water transport model in rat colon, and evaluated the effects of 5-HT3 receptor antagonists including ramosetron, alosetron, and cilansetron, and the antidiarrheal agent loperamide, in this model. In addition, the effects of 5-HT3 receptor antagonists and loperamide on abnormal defecation induced by CRF in rats were examined. Colonic water transport was measured in colonic loops in conscious rats. Centrally administered CRF (3-30 mu g/kg) markedly decreased colonic fluid loss, whereas oral administration of ramosetron (3, 30 mu g/kg), alosetron (300 mu g/kg), cilansetron (300 mu g/kg), or loperamide (3 mg/kg) significantly inhibited it. Ramosetron (1-10 mu g/kg), alosetron (10-100 mu g/kg), cilansetron (10-100 mu g/kg), or loperamide (0.3-3 mg/kg) also showed dose-dependent inhibition of CRF-induced defecation in rats. These results suggest that 5-HT3 receptors are involved in both abnormal colonic water transport and defecation induced by CRF, and that the inhibitory effects of 5-HT3 receptor antagonists on CRF-induced abnormal defecation partly result from their ameliorating action on colonic water transport. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:281 / 284
页数:4
相关论文
共 24 条
[1]   Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome [J].
Andresen, Viola ;
Camilleri, Michael ;
Busciglio, Irene A. ;
Grudell, April ;
Burton, Duane ;
Mckinzie, Sanna ;
Foxx-Orenstein, Amy ;
Kurtz, Caroline B. ;
Sharma, Vineeta ;
Johnston, Jeffrey M. ;
Currie, Mark G. ;
Zinsmeister, Alan R. .
GASTROENTEROLOGY, 2007, 133 (03) :761-768
[2]   LOPERAMIDE - SURVEY OF STUDIES ON MECHANISM OF ITS ANTIDIARRHEAL ACTIVITY [J].
AWOUTERS, F ;
MEGENS, A ;
VERLINDEN, M ;
SCHUURKES, J ;
NIEMEGEERS, C ;
JANSSEN, PAJ .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (06) :977-995
[3]  
BERRIDGE MJ, 1983, SCAND J GASTROENTERO, V18, P43
[4]   VITAMIN-E PREVENTS COLD WRAP RESTRAINT STRESS-INDUCED INTESTINAL FLUID TRANSPORT ALTERATIONS IN RATS [J].
BURDICK, S ;
CUI, NG ;
EMPEY, LR ;
FEDORAK, RN .
CANADIAN JOURNAL OF GASTROENTEROLOGY, 1994, 8 (07) :417-421
[5]   Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial [J].
Camilleri, M ;
Northcutt, AR ;
Kong, S ;
Dukes, GE ;
McSorley, D ;
Mangel, AW .
LANCET, 2000, 355 (9209) :1035-1040
[6]   Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers [J].
Camilleri, M ;
Bharucha, AE ;
Ueno, R ;
Burton, D ;
Thomforde, GM ;
Baxter, K ;
McKinzie, S ;
Zinsmeister, AR .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2006, 290 (05) :G942-G947
[7]   ROLE OF LOPERAMIDE AND PLACEBO IN MANAGEMENT OF IRRITABLE BOWEL SYNDROME (IBS) [J].
CANN, PA ;
READ, NW ;
HOLDSWORTH, CD ;
BARENDS, D .
DIGESTIVE DISEASES AND SCIENCES, 1984, 29 (03) :239-247
[8]  
Caras S, 2001, GASTROENTEROLOGY, V120, pA217, DOI 10.1016/S0016-5085(01)81077-5
[9]   Role of serotonin in the pathophysiology of the irritable bowel syndrome [J].
Crowell, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (08) :1285-1293
[10]   EFFECT OF MISOPROSTOL IN PREVENTING STRESS-INDUCED INTESTINAL FLUID SECRETION IN RATS [J].
EMPEY, LR ;
FEDORAK, RN .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1989, 38 (01) :43-48